In a recent study published in the journal PLOS ONE, researchers conducted a systematic review and meta-analyzed data on the impact of coronavirus disease 2019 (COVID-19) on male reproductive hormones and semen variables to determine whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections had an adverse impact on male fertility.
Background
The etiological agent of the COVID-19 pandemic, SARS-CoV-2, is a β-coronavirus that infects human cells by binding to the angiotensin-converting enzyme-2 (ACE-2) receptor. The ACE-2 receptor is found in the lungs, kidneys, heart, and testes, making all these organs possible entry points for the virus.
The COVID-19 pandemic was responsible for over 700 million cases and more than 7 million deaths. However, although the virus is known to primarily infect the respiratory system, research indicates that it can also adversely impact other organ systems. Studies have also found that SARS-CoV-2 infections are more severe in males than in females. Furthermore, studies have found that many males who had been infected with the earlier SARS-CoV-1 had developed orchitis or inflammation of the testes.
However, the data on the impact of SARS-CoV-2 on male reproductive health has been limited. Although some studies have reported associations between COVID-19 and decreased testosterone levels and lower semen quality, some of the findings have been considered methodologically weak.
About the study
The present study aimed to comprehensively review recent studies examining the impact of COVID-19 on male fertility and conducted a meta-analysis by comparing semen quality variables and reproductive hormone levels between infected and uninfected men to understand the influence of SARS-CoV-2 on male fertility.
The researchers used the PECO, or Population, Exposure, Comparator, and Outcomes, model to select studies that examined male patients of reproductive age who had been exposed to SARS-CoV-2. The review included both prospective and retrospective studies as long as they included COVID-19-negative controls or contained pre- and post-COVID-19 pandemic health data for the same individual. Studies that were in vitro, focused on female patients, or lacking control groups were excluded.
For the studies included in the review, the outcomes consisted of measurements of conventional semen parameters such as sperm count, ejaculate volume, sperm concentration, morphology, motility, and viability of the sperm, as well as leukocyte levels in the seminal fluid. The outcomes also included the levels of the male reproductive hormones, including testosterone, estrogen, prolactin, luteinizing hormone (LH), and follicle-stimulating hormone (FSH). The Measurements also included ratios of testosterone to LH and FSH to LH.
For the meta-analysis, the data extracted from the studies consisted of sample sizes, country of study, study design, the methods used to diagnose COVID-19, and key outcomes. The researchers used this data to calculate standardized mean differences, with extensive sensitivity analyses to avoid bias and assess sources of diversity. The parameters were also compared for changes before and after treatment for COVID-19.
Results
The review identified 40 eligible studies published from 12 different countries between 2020 and 2023 that examined the impact of SARS-CoV-2 on male reproductive health. The key findings from the meta-analysis covered the impact of COVID-19 on several aspects of male reproductive health.
The study found that COVID-19 was significantly associated with decreased ejaculate volume, with sensitivity analyses confirming consistent reductions in ejaculate volume after SARS-CoV-2 infections. However, the sensitivity analyses showed that the difference in ejaculate volume before and after COVID-19 treatment was not statistically significant, indicating that the impact of treatment may be limited. The sperm counts also decreased after SARS-CoV-2 infections, although the sensitivity analyses indicated that these reductions were marginal.
Individuals infected with SARS-CoV-2 also showed significantly lower sperm concentrations, and no changes were seen in sperm concentrations after treatment for COVID-19. This finding remained consistent even after accounting for potential study biases and diversity, reinforcing the robustness of the result. COVID-19 was also found to lower sperm viability and motility, with the difference in sperm viability remaining consistent even after the sensitivity analysis.
Comparisons between infected and uninfected individuals revealed no significant differences in sperm morphology. However, comparisons of sperm morphology in the same individual before and after SARS-CoV-2 infections revealed lower levels of morphologically normal sperm. The analysis showed that while the overall morphology differences between infected and uninfected individuals were not significant, the within-individual changes suggest that SARS-CoV-2 may have a subtle but noteworthy effect on sperm morphology.
The reproductive hormone levels were also significantly altered in COVID-19 patients, with elevated prolactin and marginally higher estrogen levels in infected men. Interestingly, the study found substantial variability in testosterone levels before and after treatment, suggesting that COVID-19’s impact on this hormone may be more complex than initially understood. However, the leukocyte levels in the seminal fluid were similar between infected and uninfected men.
Conclusions
To summarize, the study reviewed and conducted a meta-analysis of studies examining the impact of COVID-19 on male reproductive health and found that SARS-CoV-2 had a significant negative impact on male fertility, particularly on parameters such as ejaculate volume, viability, and motility of the sperm, and sperm concentration and count. Although the treatment of COVID-19 partially alleviated some of the affected parameters, the findings suggest that these improvements may not be sufficient to restore pre-infection levels, particularly for parameters like sperm concentration and motility. The study also highlighted the need for further research to fully understand the long-term effects of COVID-19 on male fertility and to explore potential therapeutic interventions.
- V. J., Ashonibare, P. J., Ashonibare, T. M., Akhigbe, & E, A. R. (2024). SARS-CoV-2 impairs male fertility by targeting semen quality and testosterone level: A systematic review and meta-analysis. PLOS ONE, 19(9), e0307396-. DOI:10.1371/journal.pone.0307396, https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0307396
News
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
Scientists Discover the Brain Protein That Helps Alzheimer’s Spread Through the Brain
Scientists have identified a brain protein that may help Alzheimer’s spread, revealing a potential new target for slowing the disease’s progression. Alzheimer’s disease is closely linked to the accumulation of a toxic form of the protein [...]
How Immune Dysregulation Contributes to Psychiatric Disorders
Introduction Growing evidence suggests that disruptions in immune function may play an important role in the development and progression of psychiatric disorders. However, immune mechanisms probably contribute more strongly in some patients than others, [...]
Electrostatic Discharge Boosts Triboelectric Nanogenerator Current and Enables DC Output
Controlled electrical discharges could enable triboelectric nanogenerators to achieve higher peak currents, extending nano-enabled energy harvesting into chemical processing and self-powered sensing. Paper: Electrostatic discharge as a breakthrough strategy for triboelectric nanogenerators. A new review [...]
Swiss laboratory uses old drugs against rare diseases
Researchers at the University of Geneva are combing through collections of approved drugs to find new therapies for rare diseases – with some success. This approach is gaining traction around the world, while pharmaceutical [...]
Nanozyme Aptasensors Show Promise for Faster Food, Health, and Environmental Testing
By pairing robust artificial enzymes with highly selective aptamers, nanozyme aptasensors could help detect disease biomarkers, pathogens, and contaminants faster, but the review shows that real-world deployment still depends on overcoming matrix interference, biofouling, [...]
Paralyzed Man Feels Sensation Again With Brain Stimulation Device
Aneuroprosthetic system has allowed a man with paralysis to grasp and lift objects and feel touch again. The device helped 42-year-old Keith Thomas of Massapequa, New York, who was paralyzed from the chest down [...]
Global Cancer Cases Could Surge 67% by 2050, New Report Warns
New data reveal major geographic disparities and highlight the urgent need for global action on prevention, early detection, and equitable access to treatment. For roughly one in five people worldwide, cancer will become part [...]
A Deadly Ebola-Like Virus Is Spreading. Are We Ready?
BU virologist Nancy Sullivan says the Bundibugyo outbreak in the Democratic Republic of the Congo underscores the need for broader outbreak preparedness. The death of a nurse marked the moment health officials recognized that [...]
Why Most Animal Viruses Never Become Human Pandemics
From receptor mismatch to risky human-animal interfaces, this article explains why spillover is common but true pandemic emergence remains rare. Introduction Humans are constantly exposed to animal viruses through farming, wildlife contact, and the [...]
